T T Lakshman, a promoter shareholder of TTK Healthcare Limited, has submitted a formal declaration confirming that no encumbrance was created on his shareholding in the company during the financial year 2025-26. The declaration, dated April 01, 2026, was filed in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Declaration Details

The filing was addressed to BSE Limited, National Stock Exchange of India Limited, and the Audit Committee of TTK Healthcare Limited. T T Lakshman confirmed that neither directly nor indirectly did he create any encumbrance on his equity shareholding during the relevant financial year. The key details of the declaration are summarised below:

Regulatory Compliance

The declaration was filed in accordance with SEBI's Takeover Regulations, which require promoters and persons acting in concert to disclose any encumbrance created, invoked, or released on shares held in a listed company. T T Lakshman's submission confirms full compliance with this regulatory requirement for the financial year 2025-26, with no encumbrance reported on the 2,67,195 equity shares of Rs. 10/- each held in TTK Healthcare Limited.

TTK Healthcare Limited has announced its compliance with SEBI's special window for transfer and dematerialization of physical securities, following the regulatory circular dated January 30, 2026. The company has fulfilled its disclosure obligations under Regulation 30 by publishing the required notice and making it available across multiple platforms.

SEBI Special Window Implementation

The Securities and Exchange Board of India has opened a special window for a period of one year, operating from February 05, 2026 to February 04, 2027. This initiative aims to facilitate the transfer and dematerialization of physical securities that were sold or purchased prior to April 01, 2019.

Regulatory Disclosure and Publication

TTK Healthcare has completed its regulatory disclosure requirements by publishing the notice in Business Standard (English Version) across four editions on Friday, April 17, 2026. The company has also shared the information on its LinkedIn page and made it available on the company website under the Investor Relations section, ensuring comprehensive stakeholder communication.

Scope and Transfer Conditions

The special window covers transfer requests that were previously submitted but rejected, returned, or not attended to due to deficiencies in documentation or processing. However, certain cases are excluded from this window, including disputes between transferor and transferee, and securities transferred to Investor Education and Protection Fund (IEPF).

Securities transferred during this special window period will be issued exclusively in dematerialized mode and will carry a mandatory lock-in period of one year from the date of registration of transfer.

Shareholder Support Services

TTK Healthcare has encouraged shareholders to take advantage of this opportunity and submit relevant documents as mentioned in the SEBI circular. The company has designated its Registrar and Transfer Agent, M/s Data Software Research Co. Pvt. Ltd., to assist shareholders with the process. For assistance, shareholders can contact the company at investorcure@ttkhealthcare.com or ttk.healthcare@dsrc-cid.in .

The disclosure was signed by Gowry A Jaishankar, DGM – Legal & Company Secretary, confirming the company's commitment to regulatory compliance and shareholder service.

Source: None/Company/INE910C01018/c97f6446512d42e6.pdf